Istanbul - Delayed Quote TRY

Deva Holding A.S. (DEVA.IS)

59.45
+0.30
+(0.51%)
As of 10:04:53 AM GMT+3. Market Open.
Currency in TRY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
14,697,227.46
15,458,482.05
16,358,568.18
8,712,735.44
2,330,367.79
Cost of Revenue
9,071,194.93
9,285,733.04
9,506,456.13
5,828,678.88
971,238.81
Gross Profit
5,626,032.53
6,172,749.01
6,852,112.05
2,884,056.56
1,359,128.98
Operating Expense
4,521,107.84
4,485,612.13
5,262,928.45
2,773,781
518,018.14
Operating Income
1,104,924.68
1,687,136.88
1,589,183.60
110,275.56
841,110.85
Net Non Operating Interest Income Expense
-2,201,448.36
-2,287,901.50
-2,075,240.57
-1,075,850.75
-215,780.13
Pretax Income
301,025.68
369,357.62
2,852,286.67
1,217,610.60
1,158,328.22
Tax Provision
-311,096.85
299,937.98
-2,035,538.96
366,549.21
-11,759.26
Net Income Common Stockholders
612,122.52
69,419.65
4,887,825.63
851,061.39
1,170,087.48
Diluted NI Available to Com Stockholders
612,122.52
69,419.65
4,887,825.63
851,061.39
1,170,087.48
Basic EPS
3.06
0.35
24.44
4.26
0.06
Diluted EPS
3.06
0.35
24.44
4.26
0.06
Basic Average Shares
200,019.29
200,019.29
200,019.29
200,019.29
20,001,928.78
Diluted Average Shares
200,019.29
200,019.29
200,019.29
200,019.29
20,001,928.78
Total Operating Income as Reported
1,918,621.02
2,799,732.77
2,901,268.35
998,376.73
1,353,282.82
Rent Expense Supplemental
34,353.17
32,993.39
6,967.03
10,186.03
527.18
Total Expenses
13,592,302.77
13,771,345.17
14,769,384.58
8,602,459.88
1,489,256.94
Net Income from Continuing & Discontinued Operation
612,122.52
69,419.65
4,887,825.63
851,061.39
1,170,087.48
Normalized Income
457,548.77
-22,070.89
4,664,763.95
746,149.15
1,138,922.99
Interest Income
644,862.95
657,286.85
300,553.92
124,758.01
17,856.41
Interest Expense
2,813,178.52
2,894,484.46
2,196,597.50
1,193,044.62
227,913.26
Net Interest Income
-2,201,448.36
-2,287,901.50
-2,075,240.57
-1,075,850.75
-215,780.13
EBIT
3,114,204.20
3,263,842.08
5,048,884.17
2,410,655.22
1,386,241.48
EBITDA
4,209,645.40
4,350,412.35
6,030,462.22
3,053,712.69
1,465,398.22
Reconciled Cost of Revenue
9,071,194.93
9,285,733.04
9,506,456.13
5,828,678.88
971,238.81
Reconciled Depreciation
1,095,441.20
1,086,570.27
981,578.05
643,057.48
79,156.75
Net Income from Continuing Operation Net Minority Interest
612,122.52
69,419.65
4,887,825.63
851,061.39
1,170,087.48
Total Unusual Items Excluding Goodwill
206,098.34
121,987.39
297,415.57
150,097.59
38,955.61
Total Unusual Items
206,098.34
121,987.39
297,415.57
150,097.59
38,955.61
Normalized EBITDA
4,003,547.06
4,228,424.96
5,733,046.65
2,903,615.10
1,426,442.62
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
51,524.59
30,496.85
74,353.89
45,185.34
7,791.12
12/31/2021 - 5/10/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

WSG.SG China Traditional Chinese Medicine Holdings Co Ltd
0.2340
+1.74%
 
WSG.BE China Traditional Chinese Medicine Holdings Co Ltd
0.2420
+0.83%
 
600812.SS North China Pharmaceutical Company.Ltd
5.95
0.00%
 
CHIZF China Traditional Chinese Medicine Holdings Co. Limited
0.3360
0.00%
 
WUHN Wuhan General Group (China), Inc.
0.0001
0.00%
 
HKMPY Hikma Pharmaceuticals PLC
51.96
0.00%
 
CPHI China Pharma Holdings, Inc.
2.2200
+5.71%
 
EBS Emergent BioSolutions Inc.
5.64
-4.08%